Abstract:In recent years, special attention has been paid to non-invasive parenteral routes of administration, which are an alternative to injectable drugs, as well as other dosage forms whose effectiveness and safety may be compromised by the administration route. At the same time, there is a paradigm shift in relation to nasal dosage forms: they are no longer considered as primarily drugs exhibiting local effects, and an increasing number of nasal medici-nal products with systemic action are appearing on the market. There is a growing interest to the nasal delivery due to the possibility of maximizing the therapeutic potential of active substances that have proven themselves in clinical practice, for example, by quick targeted action to the site of the pathological process, increased bioavailability of the drug and reduced possible side effects. The nasal cavity as a site for systemic drug absorption has anatomical and physiological features that include a relatively large surface area, a porous endothelial basement membrane, a highly vascularized epithelial layer, high total blood flow, lack of first-pass metabolism, and easy access. Therefore, the development of a convenient (nasal) dosage form of the drug with a rapid onset of action is a promising approach. When developing a new pharmaceutical product, the factors that determine bioavaila-bility should be taken into account and addressed by appropriate formulation and delivery techniques: the use of mucoadhesive components or sub-stances that modulate mucociliary clearance, variation of the viscosity or osmolarity, or selection of an appropriate dosing device. Improving intrana-sal absorption is a promising direction for obtaining drugs with improved consumer properties. In addition to the functional properties of the formula-tions, safety aspects must also be taken into account. The article provides an analysis of the limiting factors for nasal preparations, strategies for in-creasing bioavailability, permeation enhancement mechanisms, and provides examples of the application of permeation enhancers used in developed and commercially available drugs. This review gives an idea on possible to use in nasal formulations permeation enhancers which have different mode of actions.

Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems

Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review

In situ Intranasal Delivery Systems: Application Prospects and Main Pharmaceutical Aspects of Development (Review)

DEVELOPMENT OF NASAL PHARMACEUTICAL PRODUCTS FOR SYSTEMIC EXPOSURE: USE OF PERMEATION ENHANCERS TO ACHIEVE TARGET PRODUCT PROFILE

Progress in nasal drug delivery systems

Intranasal drug delivery: opportunities and toxicologic challenges during drug development

Different Methods and Formulations of Drugs and Vaccines for Nasal Administration

Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose–Brain Drug Delivery

Chances and Challenges in Intranasal Administration Delivery for Brain Disease Treatment

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting

Factors Affecting Nasal Drug Delivery and Design Strategies for Intranasal Drug Delivery.

A Comprehensive Review of Advanced Nasal Delivery: Specially Insulin and Calcitonin

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery

Advances and future perspectives of intranasal drug delivery: A scientometric review

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway

Recent progress in nanoparticulate-based intranasal delivery for treating of different central nervous system diseases

Advances in polysaccharide-based formulations for intranasal drug delivery: A review

Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

Advances in intranasal vaccine delivery: A promising non-invasive route of immunization